Sort
21,281 grants matching “influenza”
Crosstalk in RNA Mediated Innate Antiviral Responses
$61,953Curt M Horvath · Endeavor Health Clinical Operations · R21 · FY2008 · AI
HARNESSING DC SUBSETS FOR IMPROVED MUCOSAL IMMUNITY
$61,801Marcelo J Kuroda · Tulane University Of Louisiana · P51 · FY2010 · RR
DNA VACCINE FOR INDUCTION OF MUCOSAL IMMUNITY
$61,801Preston A Marx · Tulane University Of Louisiana · P51 · FY2010 · RR
NONHUMAN PRIMATE MODEL OF IMMUNOSENESCENCE AND VACCINATION
$61,801Elizabeth Schmidt Didier · Tulane University Of Louisiana · P51 · FY2010 · RR
Kaiser Washington Vaccine and Treatment Evaluation Unit
$61,660Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2024 · AI
A structural and biophysical study of the matrix proteins in influenza A/B viruses: Mechanisms of proton conduction and roles of protein-protein interactions
$61,610Huong Tran Kratochvil · University Of California, San Francisco · F32 · FY2019 · GM
Immune Responses in Otitis Prone Children
$61,440Michael E Pichichero · Rochester General Hospital (Ny) · R01 · FY2014 · DC
Pathogen Population Genomics and Evolution
$61,270William Hanage · Harvard School Of Public Health · U54 · FY2015 · GM
Avian Influenza Virus Vaccines Bearing Immunomodulators
$61,258Paul C. Roberts · Wayne State University · R21 · FY2006 · AI
Uncovering the Mechanisms Driving Seasonal Polio Incidence: A Modeling Approach Towards Endgame Strategies
$61,226Kevin Michael Bakker · University Of Michigan At Ann Arbor · F32 · FY2019 · AI
Hospital Admissions & Emergency Room Visits in Adults Associated with Influenza C
$61,087Helen Keipp Talbot · Vanderbilt University · R03 · FY2016 · AI
APOBEC PROTEINS AND RIBOVIRAL RESTRICTION
$60,854Jordan T Becker · University Of Minnesota · F32 · FY2019 · AI
Training Grant Pediatric Infectious Diseases: Viral Infections in Children
$60,815Yvonne A. Maldonado · Stanford University · T32 · FY2009 · AI
Aging and Immunity to Infection
$60,801Laura Haynes · University Of Connecticut Sch Of Med/Dnt · P01 · FY2016 · AG
Validity of Self-Reported Adult Vaccination Status
$60,798Sharon L Rolnick · Healthpartners Institute · U01 · FY2010 · IP
CSL LIMITED INACTIVATED INFLUENZA VACCINE IN ADULTS
$60,787Patricia Winokur · University Of Iowa · M01 · FY2007 · RR
Prevention of childhood hearing loss through the development of a vaccine against Moraxella catarrhalis: an understudied cause of otitis media.
$60,595Antonia Courtney Perez · State University Of New York At Buffalo · F32 · FY2017 · DC
Computational Structure-Based Protein Design
$60,585Bruce R. Donald · Duke University · R01 · FY2015 · GM
Testing Interventions to Human-Generated Occupational Airborne Infections
$60,562Edward A. Nardell · Brigham And Women'S Hospital · R01 · FY2010 · OH
7th International Symposium on NeuroVirology
$60,500Brian Wigdahl · Drexel University · R13 · FY2006 · MH
Disease Mechanisms of Prenatal and Pediatric Acquired Hydrocephalus
$60,301Joanne C Conover · University Of Connecticut Storrs · R01 · FY2022 · NS
DEVELOPMENT OF PEPTIDE-BASED ENTRY INHIBITORS FOR AVIAN INFLUENZA VIRUSES
$60,105Thomas Voss · Tulane University Of Louisiana · P51 · FY2009 · RR
Establishment and metabolic control of influenza-specific lung-resident memory B cells
$60,014S Rameeza Allie · University Of Alabama At Birmingham · F32 · FY2017 · AI
Molecular Analysis of Pathogens in Otitis Media by PCR
$60,010Garth D. Ehrlich · Allegheny-Singer Research Institute · R01 · FY2013 · DC
Hospital-Associated Respiratory Virus Infections: Molecular Epidemiology, Clinical Outcomes, and Cost-Effectiveness of Interventions - COVID-19 Administrative Supplement
$60,002Joshua Glenn Petrie · University Of Michigan At Ann Arbor · K01 · FY2021 · AI